Prevalence of infection with high-risk human papillomavirus in women in Colombia

Clinical Microbiology and Infection

Volumn 15, Issue 1, 2009, Pages 100-102

  Soto de Leon, S C ^a   Camargo, M ^a   Sanchez, R ^a   Leon, S ^a   Urquiza, M ^a   Acosta, J ^a   Monsalve, D ^a   Rodriguez, L E ^a   Patarroyo, M E ^a,b   Patarroyo, M A ^a  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Colombia; Genotypes; High risk HPV; Human papillomavirus; Multiple infections

Indexed keywords

ADULT; AGE; ALPHAPAPILLOMAVIRUS; ARTICLE; CANCER RISK; COLOMBIA; CONDYLOMA; CULTURAL FACTOR; ETHNICITY; FEMALE; GENE AMPLIFICATION; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PREGNANCY RATE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEXUAL INTERCOURSE; SEXUALITY; UTERINE CERVIX CANCER;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 59349120974     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02120.x     Document Type: Article

References (19)

1. Ault KA. Human papillomavirus vaccines and the potential for cross-protection between related HPV types. Gynecol Oncol 2007; 107(suppl 3): S31-S33.
2. Burchell AN, Winer RL, de Sanjose S, Franco EL. Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006; 24(suppl 3): S52-S61.
3. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev 2003; 16: 1-17.
4. Chaturvedi AK, Myers L, Hammons AF et al. Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol Biomarkers Prev 2005; 14: 2439-2445.
5. Combita AL, Bravo MM, Touze A, Orozco O, Coursaget P. Serologic response to human oncogenic papillomavirus types.16, 18, 31, 33, 39, 58 and 59 virus-like particles in Colombian women with invasive cervical cancer. Int J Cancer 2002; 97: 796-803.
6. Ochoa FL, Montoya LP. Mortalidad por cancer en colombia en el año 2000: Cuando aumentar no es mejorar. Rev CES Med 2003; 17: 16.
7. Lema CH, Hurtado LV, Segurondo D et al. Human papillomavirus infection among Bolivian Amazonian women. Asian Pac J Cancer Prev 2001; 2: 135-141.
8. Nelson JH, Hawkins GA, Edlund K et al. A novel and rapid PCR-based method for genotyping human papillomaviruses in clinical samples. J Clin Microbiol 2000; 38: 688-695.
9. Saiki RK, Scharf S, Faloona F et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-1354.
10. Qu W, Jiang G, Cruz Y et al. PCR detection of human papillomavirus: comparison between my09/my11 and gp5+/gp6+ primer systems. J Clin Microbiol 1997; 35: 1304-1310.
11. Lee YM, Leu SY, Chiang H, Fung CP, Liu WT. Human papillomavirus type 18 in colorectal cancer. J Microbiol Immunol Infect 2001; 34: 87-91.
12. Karlsen F, Kalantari M, Jenkins A et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 1996; 34: 2095-2100.
13. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
14. de Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur Hausen H. Classification of papillomaviruses. Virology 2004; 324: 17-27.
15. Oliveira LH, Rosa ML, Cavalcanti SM. Patterns of genotype distribution in multiple human papillomavirus infections. Clin Microbiol Infect 2008; 14: 60-65.
16. Mendez F, Munoz N, Posso H et al. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 2005; 192: 1158-1165.
17. Thomas KK, Hughes JP, Kuypers JM et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 2000; 182: 1097-1102.
18. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-428.
19. Taborda WC, Ferreira SC, Rodrigues D, Stavale JN, Baruzzi RG. Cervical cancer screening among indigenous women in the xingu Indian reservation, Central Brazil. Revista panamericana de salud publica (Pan Am J Public Health) 2000; 7: 92-96.